DD127645A5 - - Google Patents

Info

Publication number
DD127645A5
DD127645A5 DD195824A DD19582476A DD127645A5 DD 127645 A5 DD127645 A5 DD 127645A5 DD 195824 A DD195824 A DD 195824A DD 19582476 A DD19582476 A DD 19582476A DD 127645 A5 DD127645 A5 DD 127645A5
Authority
DD
German Democratic Republic
Application number
DD195824A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD127645A5 publication Critical patent/DD127645A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DD195824A 1975-11-18 1976-11-17 DD127645A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4737375 1975-11-18

Publications (1)

Publication Number Publication Date
DD127645A5 true DD127645A5 (en:Method) 1977-10-05

Family

ID=10444739

Family Applications (1)

Application Number Title Priority Date Filing Date
DD195824A DD127645A5 (en:Method) 1975-11-18 1976-11-17

Country Status (28)

Country Link
US (5) US4113728A (en:Method)
JP (1) JPS5262273A (en:Method)
AR (3) AR217411A1 (en:Method)
AT (1) AT355017B (en:Method)
AU (2) AU504599B2 (en:Method)
BE (1) BE848371A (en:Method)
BG (4) BG24810A3 (en:Method)
CA (1) CA1064511A (en:Method)
CH (1) CH627465A5 (en:Method)
CS (4) CS192594B2 (en:Method)
DD (1) DD127645A5 (en:Method)
DE (1) DE2652201A1 (en:Method)
DK (1) DK517776A (en:Method)
ES (3) ES453420A1 (en:Method)
FI (1) FI763285A7 (en:Method)
FR (1) FR2332019A1 (en:Method)
HU (1) HU173958B (en:Method)
IL (1) IL50690A (en:Method)
NL (1) NL7612796A (en:Method)
NO (1) NO763922L (en:Method)
NZ (1) NZ182325A (en:Method)
PH (1) PH13918A (en:Method)
PL (1) PL193742A1 (en:Method)
PT (1) PT65851B (en:Method)
RO (4) RO69608A (en:Method)
SE (1) SE7612919L (en:Method)
SU (4) SU682129A3 (en:Method)
ZA (1) ZA766489B (en:Method)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ182325A (en) * 1975-11-18 1979-03-16 Beecham Group Ltd 2-substituted-1,2-benzisothiazol-3-ones
DE2602643C2 (de) * 1976-01-24 1984-12-20 Bayer Ag, 5090 Leverkusen 1,2-Benzisothiazolinone-3, Verfahren zu ihrer Herstellung sowie Arzneimittel
US4190663A (en) * 1976-01-24 1980-02-26 Bayer Aktiengesellschaft Anti-thrombotic 1,2-benzisothiazolin-3-ones
DE2860750D1 (en) * 1977-06-20 1981-09-17 Beecham Group Plc Antithrombotic 2-(gamma-(1-piperidinyl)propyl)1,2-benzisothiazol 3-one, its pharmaceutically acceptable acid addition salts, their preparation and their compositions
DE2860430D1 (en) * 1977-10-08 1981-02-26 Beecham Group Ltd Antithrombotic compositions containing benzisothiazolones
EP0026791B1 (en) * 1979-10-08 1984-05-02 Merck & Co. Inc. 2-aryl-1,2-benzisothiazolinone-1,1-dioxides and pharmaceutical compositions containing them
DE3226284A1 (de) * 1982-07-14 1984-01-19 A. Nattermann & Cie GmbH, 5000 Köln Neue benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3238006A1 (de) * 1982-10-13 1984-04-19 Bayer Ag, 5090 Leverkusen Azolyl-methylamine, ihre herstellung und verwendung in mikrobiziden mitteln
DE3500577A1 (de) * 1985-01-10 1986-07-10 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 1,2-benzisothiazolonen
US4732984A (en) * 1985-10-17 1988-03-22 American Home Products Corporation Piperazinoisothiazolones with psychotropic activity
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US5128457A (en) * 1988-07-01 1992-07-07 Miles Inc. Chromogenic thiol indicators based on an isobenzothiazolone ring system
CA1340759C (en) * 1988-07-01 1999-09-21 James P. Albarella Isobenzothiazolone chromogenic thiol indicators and their derivatives
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
CA2738314C (en) * 2008-09-23 2017-01-10 Georgetown University 1,2-benzisothiazolinone and isoindolinone derivatives
US9428472B2 (en) 2011-08-16 2016-08-30 Georgetown University Methods of treating bacterial infections with 1,2-benzisothiazolinone and isoindolinone derivatives
US20180318818A1 (en) * 2015-10-19 2018-11-08 Emory University Redox Dehydration Coupling Catalysts and Methods Related Thereto

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE565380A (en:Method) * 1957-03-08
US3012039A (en) * 1958-03-14 1961-12-05 Ici Ltd 2-p-chlorobenzyl-1, 2-benzisothiazolone
DE1147947B (de) * 1961-07-25 1963-05-02 Knoll Ag Verfahren zur Herstellung neuer 1, 2-Benzisothiazolone
SE392103B (sv) * 1970-04-27 1977-03-14 Sherwin Williams Co Sett att framstella 1,2-bensisotiazolin-3-oner
US3661974A (en) * 1970-04-27 1972-05-09 Sherwin Williams Co 2-carbalkoxy-phenyl sulfenamides
NZ182325A (en) * 1975-11-18 1979-03-16 Beecham Group Ltd 2-substituted-1,2-benzisothiazol-3-ones
GB1582214A (en) * 1977-05-31 1981-01-07 Beecham Group Ltd Antithrombotic compositions
DE2734882A1 (de) * 1977-08-03 1979-02-22 Basf Ag 3- eckige klammer auf 4-(1,3-diazacycloalken-2-yl)-phenyl eckige klammer zu -1,2-benzisothiazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
BG24811A3 (bg) 1978-05-12
US4350702A (en) 1982-09-21
NZ182325A (en) 1979-03-16
NO763922L (en:Method) 1977-05-20
CH627465A5 (de) 1982-01-15
CS192592B2 (en) 1979-08-31
BG24808A3 (bg) 1978-05-12
NL7612796A (nl) 1977-05-23
DK517776A (da) 1977-05-19
RO75730A (ro) 1981-02-28
ZA766489B (en) 1977-10-26
IL50690A0 (en) 1976-12-31
PH13918A (en) 1980-11-04
PL193742A1 (pl) 1979-05-21
US4113728A (en) 1978-09-12
AU1916376A (en) 1978-05-04
RO69608A (ro) 1982-07-06
FI763285A7 (en:Method) 1977-05-19
BG24809A3 (bg) 1978-05-12
SU679141A3 (ru) 1979-08-05
US4212979A (en) 1980-07-15
AU4716379A (en) 1979-09-27
AR217449A1 (es) 1980-03-31
AU504599B2 (en) 1979-10-18
ATA849176A (de) 1979-07-15
ES465174A1 (es) 1978-10-01
AR215271A1 (es) 1979-09-28
AU520890B2 (en) 1982-03-04
SU671728A3 (ru) 1979-06-30
CS192593B2 (en) 1979-08-31
CS192594B2 (en) 1979-08-31
IL50690A (en) 1980-01-31
PT65851A (en) 1976-12-01
CS192570B2 (en) 1979-08-31
SE7612919L (sv) 1977-05-19
BG24810A3 (bg) 1978-05-12
RO75777A (ro) 1981-02-28
AR217411A1 (es) 1980-03-31
JPS5262273A (en) 1977-05-23
CA1064511A (en) 1979-10-16
BE848371A (fr) 1977-05-16
HU173958B (hu) 1979-09-28
FR2332019B1 (en:Method) 1983-05-20
ES465173A1 (es) 1978-10-01
PT65851B (en) 1978-05-15
DE2652201A1 (de) 1977-06-02
US4243669A (en) 1981-01-06
ES453420A1 (es) 1978-02-16
SU701536A3 (ru) 1979-11-30
FR2332019A1 (fr) 1977-06-17
RO75540A (ro) 1980-11-30
AT355017B (de) 1980-02-11
US4212872A (en) 1980-07-15
SU682129A3 (ru) 1979-08-25

Similar Documents

Publication Publication Date Title
BG20847A1 (en:Method)
BG22256A1 (en:Method)
BG22685A1 (en:Method)
BG22704A2 (en:Method)
BG22964A1 (en:Method)
BG23106A1 (en:Method)
CH452675A4 (en:Method)
CH584587A5 (en:Method)
CH587155A5 (en:Method)
CH588169A5 (en:Method)
CH588716A5 (en:Method)
CH589513A5 (en:Method)
CH591786A5 (en:Method)
CH592193A5 (en:Method)
CH593052A5 (en:Method)
CH593405A5 (en:Method)
CH593444A5 (en:Method)
CH594114A5 (en:Method)
CH594804A5 (en:Method)
CH595517A5 (en:Method)
CH597393A5 (en:Method)
CH597449A5 (en:Method)
CH597651A5 (en:Method)
CH597707A5 (en:Method)
CH599079A5 (en:Method)